OBSEVA
ObsEva SA is a Swiss-based, speciality biopharmaceutical company dedicated to the development of innovative drugs for women's reproductive medicine. ObsEva's main focus is on therapies for preterm labor. ObsEva was founded in November 2012, by Ernest Loumaye MD, PhD and André Chollet PhD. Ernest Loumaye is a specialist in female reproductive medicine with 20 years of experience in the biopharmaceutical industry. Ernest Loumaye was previously Co-Founder and CEO of PregLem SA, a successful bio... pharmaceutical company which was acquired by Gedeon Richter in 2010. André Chollet is specialist in medicinal and pharmaceutical chemistry with more than 30 years of experience in diverse positions in the biopharmaceutical industry, including in Biogen, GSK and Merck Serono. André Chollet was responsible for the preterm labor program at Serono before the acquisition of the company by Merck KGaA.
OBSEVA
Social Links:
Industry:
Biotechnology Pharmaceutical Therapeutics Women's
Founded:
2012-01-01
Address:
Plan-les-ouates, Geneve, Switzerland
Country:
Switzerland
Website Url:
http://www.obseva.com
Total Employee:
11+
Status:
Active
Contact:
+41 (0)22 552 3840
Email Addresses:
[email protected]
Total Funding:
228.37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Alphamab Oncology
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Hookipa Pharma
Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Reata Pharmaceuticals
Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - ObsEva
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - ObsEva
Omega Funds
Omega Funds investment in Post-IPO Equity - ObsEva
Aisling Capital
Aisling Capital investment in Post-IPO Equity - ObsEva
Venrock
Venrock investment in Post-IPO Equity - ObsEva
New Leaf Venture Partners
New Leaf Venture Partners investment in Post-IPO Equity - ObsEva
New Enterprise Associates
New Enterprise Associates investment in Post-IPO Equity - ObsEva
Sofinnova Investments
Sofinnova Investments investment in Post-IPO Equity - ObsEva
Sphera Global Healthcare Fund
Sphera Global Healthcare Fund investment in Post-IPO Equity - ObsEva
New Enterprise Associates
New Enterprise Associates investment in Series B - ObsEva
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-02 | ObsEva Announces Appointment of Dr. Brandi Howard as Chief Clinical Officer |
| 2021-09-30 | ObsEva Announces Appointment of Luigi Marro as Chief Transformation Officer |
| 2020-04-06 | ObsEva SA Announces New Interim Chief Financial Officer |
Official Site Inspections
http://www.obseva.com Semrush global rank: 3.87 M Semrush visits lastest month: 3.35 K
- Host name: web-wb-20.dfinet.ch
- IP address: 195.70.7.125
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich
More informations about "ObsEva"
ObsEva - Crunchbase Company Profile & Funding
ObsEva is a speciality biopharmaceutical company developing drugs for women’s reproductive medicine.See details»
About Us - ObsEva
ObsEva is led by a strong management team with substantial experience in successfully developing and commercializing pharmaceutical products in our target market. ObsEva’s team …See details»
ObsEva - Contacts, Employees, Board Members, Advisors & Alumni
ObsEva is a speciality biopharmaceutical company developing drugs for women’s reproductive medicine.See details»
ObsEva Announces Wind-Down of Operations and Notifies SIX …
Geneva, Switzerland – 28 February 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's health, today announced that it will wind …See details»
Leadership Team - ObsEva
Meet our Executive Team Our executive team combines successful track records in reproductive health with cross-functional, global expertise to help make a significant difference in the lives of women.See details»
ObsEva Company Profile - Office Locations, Competitors, Revenue ...
ObsEva has 5 employees across 3 locations and $92.9 m in total funding,. See insights on ObsEva including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
ObsEva - AnnualReports.com
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through …See details»
ObsEva Announces Update Towards its Strategic Reorganization …
Mar 13, 2023 About ObsEva ObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy.See details»
ObsEva Announces Strategic Reorganization to Consolidate …
Feb 24, 2023 Board of Directors and Management Changes In connection with the reorganization, ObsEva’s Chairwoman, Annette Clancy, and Board members Brian …See details»
ObsEva SA - LinkedIn
ObsEva. Nature meets Nurture | Innovating Women’s Reproductive Health and Pregnancy Therapeutics ObsEva is a clinical-stage biopharmaceutical company focused on the clinical …See details»
ObsEva - Funding, Financials, Valuation & Investors
ObsEva is a speciality biopharmaceutical company developing drugs for women’s reproductive medicine.See details»
Contact - ObsEva
For general enquiries, please send email to: Contact For CEO Office, please send an email to: Shauna Dillon For investor relations, please send an email to: IR For media relations in U.S, …See details»
ObsEva Announces Corporate Updates - GlobeNewswire
Jul 27, 2022 ObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy.See details»
ObsEva SA (OBSEF) Stock Price, News, Quote & History - Yahoo …
Find the latest ObsEva SA (OBSEF) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
ObsEva Announces Strategic Reorganization to Consolidate
Feb 24, 2023 ObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy. ObsEva has established a development program …See details»
News & Events - ObsEva
May 9, 2019 Discover how ObsEva is making news in the field of reproductive health and pregnancy therapeutics.See details»
ObsEva Announces Progress on Restructuring Initiatives - Yahoo …
Sep 13, 2022 GENEVA, Switzerland – September 13, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing novel therapies for women’s health, …See details»
Partnering - ObsEva
Partnering with pharmaceutical companies: Should you represent a pharmaceutical company seeking a strong and committed partner for the development and the commercialization of a …See details»
News and Events | ObsEva
Jul 12, 2019 Discover how ObsEva is making news and search for upcoming or recent event information.See details»